title: Acute Promyelocytic Leukemia After Treatment of Metastatic Castration-Resistant Prostate Cancer With Radium-223.
authors.affiliation: Section of Hematology/Medical Oncology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA. Electronic address: uodo@tulane.edu.
authors.forename: Ugochukwu
authors.initials: U
authors.lastname: Odo
authors.affiliation: Section of Hematology/Medical Oncology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA.
authors.forename: Ashwin K
authors.initials: AK
authors.lastname: Vasudevamurthy
authors.affiliation: Department of Medicine and Urology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA.
authors.forename: Oliver
authors.initials: O
authors.lastname: Sartor
mesh_terms: D000368:Aged; D001859:Bone Neoplasms / Q000532:radiotherapy* / Q000556:secondary; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute; D007953:Leukemia, Radiation-Induced; D008297:Male; D064129:Prostatic Neoplasms, Castration-Resistant / Q000473:pathology / Q000532:radiotherapy*; D011883:Radium / Q000009:adverse effects*
chemical_list: C000615150:Radium-223; D011883:Radium
keywords: Acute promyelocytic leukemia; Bone metastases; Castrate-resistant prostate cancer; Leukemia; Radium-223